Medtronic is likely to attempt a renegotiation of its $43 billion acquisition of Covidien now that the U.S. Treasury Dept. has changed the rules on tax inversion deals.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1taVRVv
Cap comentari:
Publica un comentari a l'entrada